Amrize (AMRZ) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Amrize (NYSE: AMRZ):

• 12/18/2025 – Amrize had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $70.00 price target on the stock.
• 12/17/2025 – Amrize had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Amrize was downgraded by analysts at Royal Bank Of Canada from an “outperform” rating to a “sector perform” rating. They now have a $60.00 price target on the stock, up previously from $56.00.
• 12/8/2025 – Amrize was given a new $59.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
• 11/25/2025 – Amrize is now covered by analysts at Vertical Research. They set a “hold” rating and a $54.00 price target on the stock.
• 11/14/2025 – Amrize is now covered by analysts at Stephens. They set an “overweight” rating and a $60.00 price target on the stock.
• 11/3/2025 – Amrize is now covered by analysts at Oddo Bhf. They set a “neutral” rating on the stock.
• 11/3/2025 – Amrize had its price target raised by analysts at Citigroup Inc. from $60.00 to $63.00. They now have a “buy” rating on the stock.
• 11/3/2025 – Amrize had its price target raised by analysts at UBS Group AG from $52.00 to $53.00. They now have a “neutral” rating on the stock.
• 10/30/2025 – Amrize had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 10/30/2025 – Amrize had its price target raised by analysts at Wells Fargo & Company from $57.00 to $58.00. They now have an “overweight” rating on the stock.
• 10/29/2025 – Amrize was given a new $61.00 price target on by analysts at Morgan Stanley. They now have an “overweight” rating on the stock.
• 10/25/2025 – Amrize was upgraded by analysts at Wall Street Zen to a “hold” rating.

Insider Buying and Selling at Amrize

In related news, Director Nicholas C. Gangestad purchased 2,000 shares of the business’s stock in a transaction dated Wednesday, November 19th. The shares were acquired at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the acquisition, the director owned 4,958 shares of the company’s stock, valued at $234,711.72. The trade was a 67.61% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CTO Roald Brouwer acquired 4,000 shares of Amrize stock in a transaction that occurred on Friday, October 31st. The shares were purchased at an average price of $51.77 per share, with a total value of $207,080.00. Following the purchase, the chief technology officer owned 9,000 shares in the company, valued at $465,930. This represents a 80.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders purchased 65,000 shares of company stock valued at $3,399,720.

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.